Patent Assignment
Reel/Frame 037847/0121
Corrective Assignment to Correct Schedule of the Executed Inside the Assignment Document. Previously Recorded at Reel: 033600 Frame: 0791. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2016-02-16
Pages: 11
Assignor
ENZON PHARMACEUTICALS, INC.
Executed: 2013-10-24
Assignee
SANTARIS PHARMA A/S
FREMTIDSVEJ 3, HOERSHOLM, 2970, DENMARK
Covered Properties
(4)
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 6, 2006
From: WESTERGAARD, MAJKEN; THRUE, CHARLOTTE A.; RASMUSSEN, FRANK W.; HANSEN, HENRIK F.
To: SANTARIS PHARMA A/S
Reel/Frame 018088/0007 →
Assignment of Assignor's Interest
Jul 23, 2007
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019589/0140 →
Assignment of Assignor's Interest
Sep 21, 2007
From: SANTARIS PHARMA A/S
To: ENZON, INC.
Reel/Frame 019861/0738 →
Amended and Restated Assginment of 50% Interest to Enzon Pharmaceuticals, Inc. Effective July 26, 2006
Apr 5, 2009
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 022505/0620 →
Assignment of Assignor's Interest
Aug 25, 2014
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 033600/0791 →
Merger and Change of Name
Apr 13, 2015
From: SANTARIS PHARMA A/S; ROCHE INNOVATION CENTER COPENHAGEN A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 035421/0435 →